{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"pt-141-chemo","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/pt-141-chemo/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/pt-141-chemo/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"pt-141-chemo","title":"PT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathways","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:04.558Z","body_excerpt":"## What's breaking down\n\nChemotherapy often disrupts multiple body systems at once. Nerve endings in the periphery can suffer direct toxicity, producing neuropathic pain or numbness. Hormonal shifts and fatigue commonly reduce overall energy and drive. Sexual function layers are frequently hit: desire and arousal signals from the central nervous system can weaken even when physical sensation remains intact. These changes are not uniform; some patients report preserved physical response but lowered motivation, while others experience combined pain and motivational loss. The net result is that repair pathways for tissue and neural signaling fall behind the ongoing stress of treatment.\n\nNo single peptide or drug reverses the full picture. The sections below examine two compounds discussed in this context, PT-141 and gabapentin/pregabalin, through the lens of what each is studied to do at specific layers.\n\n## Why PT-141 might help you\n\nPT-141 (bremelanotide) is studied for its action on melanocortin receptors in the brain. These receptors sit in pathways that influence sexual motivation and arousal.\n\nIf your chemotherapy experience includes reduced sexual desire or difficulty with arousal despite preserved sensation, the logic chain runs like this: melanocortin activation is one documented route to central nervous system signaling for desire; PT-141 engages that route directly rather than acting on blood vessels or local tissue; therefore, for the CNS arousal layer, it is discussed as a compound that targets a signaling step instead of simply masking downstream symptoms.\n\nThis framing stays at the level of studied mechanisms. It does not claim PT-141 repairs chemotherapy-damaged nerves or restores hormone levels. It addresses one functional layer that chemo can blunt.\n\n## Why Gabapentin / pregabalin matters for you\n\nGabapentin and pregabalin bind calcium channels in nerve cells and reduce excitatory neurotransmitter release. In practice they dampen pain signal transmission.\n\nIf chemotherapy has produced neuropathic pain that interferes with daily function or sleep, the steps are: these drugs suppress the pain signal at the nerve level; they do not promote nerve regrowth or reverse the underlying damage; therefore they reduce mechanical and sensory load for the patient while leaving the degenerative process itself unaddressed.\n\nThe trade-off is straightforward: symptom relief can improve quality of life and indirectly support other repair efforts by allowing better rest and activity, yet it does not substitute for pathways aimed at tissue or neural recovery.\n\n## How these fit together\n\nPT-141 and gabapentin/pregabalin target separate layers. One engages central arousal signaling; the other modulates peripheral pain transmission. When both layers are active after chemotherapy, the compounds address different parts of the picture without overlapping mechanisms. Any combined use would require separate evaluation of each layer rather than assuming additive repair effects.\n\n## What the evidence actually shows\n\nHuman data for PT-141 center on hypoactive sexual desire disorder in premenopausal women without cancer. Two phase 3 randomized trials measured desire scores and distress; participants receiving bremelanotide showed statistically higher desire metrics than placebo (human|source s0, s15). Long-term open-label follow-up tracked safety out to 18 months in the same population (human|source s18). No published randomized trials exist in chemotherapy or cancer-survivor cohorts (human|source s17).\n\nEarly small studies in men with erectile dysfunction measured rapid increases in erectile activity after PT-141 dosing, again outside the chemotherapy setting (human|source s14).\n\nAnimal and mechanistic work established melanocortin receptor agonism as the primary pathway, but these do not directly model chemotherapy neuropathy (preclinical).\n\nGabapentin and pregabalin have multiple human trials in neuropathic pain, including some chemotherapy-","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"Two phase 3 randomized trials showed bremelanotide improved desire scores versus placebo in premenopausal women with HSDD.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0"],"source_status":"sourced","why_material":"Establishes the only robust human efficacy data available for PT-141.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"No published randomized trials study bremelanotide in cancer survivors or chemotherapy patients.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s17"],"source_status":"sourced","why_material":"Directly limits claims about the specific cross in the slug.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"One randomized trial found pregabalin superior to gabapentin for cancer-related neuropathic pain on VAS scores and opioid use.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s26"],"source_status":"sourced","why_material":"Provides the comparative human data for the drug section.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"PT-141 acts via melanocortin receptor agonism in central pathways linked to sexual motivation.","tier":"mechanistic","weight":0.3,"section":"Why PT-141 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Explains the targeted layer without implying repair of chemo damage.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c5","text":"Reddit and X mentions of PT-141 with chemotherapy are sparse personal accounts without controlled verification.","tier":"anecdotal","weight":0.3,"section":"What people say on Reddit","slot":null,"interaction_risk":false,"status":"active","source_ids":["s29"],"source_status":"sourced","why_material":"Separates anecdote from trial data as required.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Bremelanotide significantly improves sexual desire and related distress in premenopausal women with hypoactive sexual distress disorder","summary":"Phase 3 trial results in HSDD population.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"e04014a8183d2125584146829ef6dc66ada79a9b4e2fd880fc6fc000a4c5ed49"},{"id":"s17","type":"review","url":"https://www.sciencedirect.com/topics/medicine-and-dentistry/bremelanotide","title":"Bremelanotide - an overview","quote":"There are no published trials studying bremelanotide in cancer survivors","summary":"Explicit statement on lack of cancer data.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"3ce493726278e9f30d79396fb2f74f41195d7afdf45af5722c190a91b082ab7f"},{"id":"s2","type":"other","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","summary":"Mechanism and approved use summary.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"27ffeff75b5fda7c4f5a8cb5c49ae0deb12d6be69206075aaf0cc8046a1a39cd"},{"id":"s26","type":"pubmed","url":"https://www.mypcnow.org/fast-fact/ff-289-a-comparison-of-pregabalin-and-gabapentin-in-palliative-care/","title":"A Comparison of Pregabalin and Gabapentin in Palliative Care","quote":"There has been only one study comparing the efficacy of gabapentin and pregabalin in neuropathic cancer pain.","summary":"Details the single comparative trial in cancer pain.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"45356cd9e1e7c3db04d54bb3c349c9fe7a720916029a92cf07b7e985edb316f5"},{"id":"s29","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1mz2i08/pt1_beginners_guide_using_pt141_low_and_slow_for/","title":"Beginner's Guide: Using PT-141","quote":"If you can get a hold of this (it’s often prescribed for chemo nausea or severe nausea cases","summary":"Example anecdotal mention touching on chemo context.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"70bdf941e6d729c4092b1345738e5cfe5c7ab0814a1edee363efe62abd49ad95"}],"anecdotal_sources":[{"id":"s29","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1mz2i08/pt1_beginners_guide_using_pt141_low_and_slow_for/","title":"Beginner's Guide: Using PT-141","quote":"If you can get a hold of this (it’s often prescribed for chemo nausea or severe nausea cases","summary":"Example anecdotal mention touching on chemo context.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"70bdf941e6d729c4092b1345738e5cfe5c7ab0814a1edee363efe62abd49ad95"}],"scientific_sources":[{"id":"s0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials","quote":"Bremelanotide significantly improves sexual desire and related distress in premenopausal women with hypoactive sexual distress disorder","summary":"Phase 3 trial results in HSDD population.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"e04014a8183d2125584146829ef6dc66ada79a9b4e2fd880fc6fc000a4c5ed49"},{"id":"s17","type":"review","url":"https://www.sciencedirect.com/topics/medicine-and-dentistry/bremelanotide","title":"Bremelanotide - an overview","quote":"There are no published trials studying bremelanotide in cancer survivors","summary":"Explicit statement on lack of cancer data.","claim_ids":["c2"],"link_status":"http_403","quote_status":"unverified","hash":"3ce493726278e9f30d79396fb2f74f41195d7afdf45af5722c190a91b082ab7f"},{"id":"s26","type":"pubmed","url":"https://www.mypcnow.org/fast-fact/ff-289-a-comparison-of-pregabalin-and-gabapentin-in-palliative-care/","title":"A Comparison of Pregabalin and Gabapentin in Palliative Care","quote":"There has been only one study comparing the efficacy of gabapentin and pregabalin in neuropathic cancer pain.","summary":"Details the single comparative trial in cancer pain.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"45356cd9e1e7c3db04d54bb3c349c9fe7a720916029a92cf07b7e985edb316f5"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"pt-141-chemo","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":5,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":5,"claims_total":5,"sources":5,"anecdotal":1,"scientific":3,"user_reports":0,"questions":0,"evidence_ingests":0}}